Figure 1.
Figure 1. MGd cytotoxicity in chemotherapy-sensitive and highly resistant myeloma cell lines. Cell number as determined by Coulter counting following 24-hour, 48-hour, and 72-hour exposure to 50 μM MGd (▵) in the chemotherapy-sensitive cell line, 8226-RPMI (A), and the highly chemotherapy-resistant line, DOX-10V (B). Varying concentrations of ascorbate (Asc) were added to cell cultures at time 0 (50 μM, ○; 100μM, ×). Mannitol control is indicated by ⋄; ascorbate control, by □. PI was measured by flow cytometric analysis under the same conditions in 8226-RPMI (C) and DOX-10V (D). A dose-response analysis was completed at 48 hours using increasing MGd doses with a constant ascorbate concentration (50 μM) in 8226-RPMI cells (E). Control consisted of mannitol/ascorbate and MGd alone (data not shown). Results showing the mean and the SD were obtained from triplicate measurements at each time point.

MGd cytotoxicity in chemotherapy-sensitive and highly resistant myeloma cell lines. Cell number as determined by Coulter counting following 24-hour, 48-hour, and 72-hour exposure to 50 μM MGd (▵) in the chemotherapy-sensitive cell line, 8226-RPMI (A), and the highly chemotherapy-resistant line, DOX-10V (B). Varying concentrations of ascorbate (Asc) were added to cell cultures at time 0 (50 μM, ○; 100μM, ×). Mannitol control is indicated by ⋄; ascorbate control, by □. PI was measured by flow cytometric analysis under the same conditions in 8226-RPMI (C) and DOX-10V (D). A dose-response analysis was completed at 48 hours using increasing MGd doses with a constant ascorbate concentration (50 μM) in 8226-RPMI cells (E). Control consisted of mannitol/ascorbate and MGd alone (data not shown). Results showing the mean and the SD were obtained from triplicate measurements at each time point.

Close Modal

or Create an Account

Close Modal
Close Modal